Here is a list of stock that is at 52 week low. Do your research on this stock, some can be big winner and some can file bankruptcy. So becareful playing this stock. My pick are ANTH, AEZS, VTUS, BIOD,ARQL, DCTH, IDIX, APPY, AVEO, OMER, AMRN, MNKD, ITMN, IMGN.
OMER 1st Quarter 2013 Phase 3
Company , Ticker, Market cap, 52 week %, Last Price
Anthera Pharmaceuticals Inc (March 31st phase 3) | ANTH | $ | 52.59M | -91.74 | 0.66 |
Tranzyme Inc | TZYM | $ | 14.35M | -87.13 | 0.52 |
Chelsea Therapeutics International Ltd. | CHTP | $ | 54.35M | -81.86 | 0.81 |
CARDIOME PHARMA CORP | CRME | $ | 30.14M | -79.29 | 0.49 |
Oncothyreon Inc (USA) | ONTY | $ | 115.52M | -73.66 | 2.02 |
AEterna Zentaris Inc. (USA) March 31st phase 3 | AEZS | $ | 73.20M | -73.24 | 2.89 |
Cell Therapeutics Inc | CTIC | $ | 139.67M | -72.57 | 1.44 |
Ventrus Biosciences Inc 2013 | VTUS | $ | 32.21M | -71.99 | 2.49 |
Progenics Pharmaceuticals, Inc. | PGNX | $ | 98.02M | -71.64 | 2.89 |
Biodel Inc 9/30/2013 phase 2 | BIOD | $ | 38.28M | -69.23 | 2.76 |
Stereotaxis Inc | STXS | $ | 17.68M | -69.18 | 2.25 |
Opexa Therapeutics Inc. | OPXA | $ | 7.09M | -69.06 | 1.23 |
MAKO Surgical Corp. | MAKO | $ | 482.70M | -68.75 | 11.24 |
BG Medicine, Inc. | BGMD | $ | 42.64M | -68.72 | 2.08 |
Telik, Inc. | TELK | $ | 4.63M | -68.15 | 1.72 |
OXiGENE, Inc. | OXGN | $ | 7.03M | -67.77 | 4.10 |
ArQule, Inc. Begins phase 3 | ARQL | $ | 162.40M | -67.48 | 2.61 |
Standard Register Co | SR | $ | 19.02M | -67.31 | 0.65 |
Biosante Pharmaceuticals Inc | BPAX | $ | 34.89M | -65.33 | 1.42 |
Biota Pharmaceuticals Inc | BOTA | $ | 18.65M | -64.98 | 3.95 |
Delcath Systems, Inc. May, june fda committee | DCTH | $ | 113.36M | -64.55 | 1.51 |
Neurometrix Inc | NURO | $ | 6.16M | -64.44 | 0.48 |
Oxygen Biotherapeutics, Inc. | OXBT | $ | 23.96M | -64.21 | 0.72 |
China Pharma Holdings, Inc. | CPHI | $ | 11.77M | -63.76 | 0.27 |
Idenix Pharmaceuticals, Inc. phase 2 3/31/2013 | IDIX | $ | 650.67M | -63.15 | 4.86 |
Arrowhead Research Corp | ARWR | $ | 29.88M | -62.66 | 1.91 |
MELA Sciences, Inc. | MELA | $ | 54.04M | -61.49 | 1.71 |
Zeltiq Aesthetics Inc | ZLTQ | $ | 154.78M | -61.17 | 4.33 |
Echo Therapeutics Inc | ECTE | $ | 33.37M | -58.91 | 0.83 |
Dendreon Corporation | DNDN | $ | 918.19M | -57.32 | 5.95 |
BioCryst Pharmaceuticals, Inc. | BCRX | $ | 83.95M | -57.14 | 1.65 |
Maxygen, Inc. | MAXY | $ | 69.50M | -56.06 | 2.50 |
Bacterin International Holdings Inc | BONE | $ | 55.38M | -55.63 | 1.30 |
Biostar Pharmaceuticals Inc | BSPM | $ | 10.79M | -55.00 | 1.08 |
Electromed, Inc. | ELMD | $ | 11.20M | -54.61 | 1.38 |
Savient Pharmaceuticals, Inc. | SVNT | $ | 76.70M | -54.55 | 1.05 |
WorldHeart Corporation (USA) | WHRT | $ | 7.70M | -53.33 | 0.00 |
Catalyst Pharmaceutical Partners, Inc. | CPRX | $ | 17.72M | -52.78 | 0.51 |
Cleveland BioLabs, Inc. | CBLI | $ | 69.06M | -51.23 | 1.59 |
Venaxis Inc 2013 | APPY | $ | 17.98M | -51.15 | 2.33 |
STAAR Surgical Company | STAA | $ | 203.89M | -50.36 | 5.57 |
Merus Labs International Inc (USA) | MSLI | $ | 30.71M | -48.98 | 1.00 |
Zogenix, Inc. March 1st, 2013 | ZGNX | $ | 141.94M | -48.54 | 1.41 |
Northwest Biotherapeutics, Inc | NWBO | $ | 41.36M | -48.33 | 3.10 |
Cardium Therapeutics Inc | CXM | $ | 24.85M | -48.21 | 0.19 |
Rexahn Pharmaceuticals, Inc. | RNN | $ | 31.46M | -48.03 | 0.33 |
Alexza Pharmaceuticals, Inc. | ALXA | $ | 64.95M | -46.92 | 4.14 |
Anacor Pharmaceuticals Inc | ANAC | $ | 138.01M | -46.26 | 3.88 |
Metabolix, Inc. | MBLX | $ | 49.40M | -46.07 | 1.44 |
Pacific Biosciences of California | PACB | $ | 141.53M | -45.69 | 2.52 |
Genetic Technologies Limited (ADR) | GENE | $ | 37.49M | -45.62 | 2.42 |
Amicus Therapeutics, Inc. 2nd quarter | FOLD | $ | 185.44M | -44.44 | 3.75 |
Senomyx Inc. | SNMX | $ | 71.38M | -44.03 | 1.78 |
Natural Alternatives International, Inc. | NAII | $ | 36.33M | -43.04 | 5.24 |
VirtualScopics Inc | VSCP | $ | 18.80M | -42.55 | 0.63 |
Horizon Pharma Inc | HZNP | $ | 131.79M | -42.32 | 2.14 |
SKYSTAR BIO-PHARMACEUTICAL COMPANY | SKBI | $ | 13.38M | -42.30 | 1.76 |
Rockwell Medical Inc | RMTI | $ | 137.38M | -42.26 | 6.45 |
Apricus Biosciences Inc | APRI | $ | 86.72M | -42.23 | 2.90 |
Halozyme Therapeutics, Inc. | HALO | $ | 735.96M | -42.16 | 6.53 |
No comments:
Post a Comment